Metastatic Colorectal Cancer: Incorporating the Latest Developments and Supporting Patient-Centered Treatment

Create optimal dosing plans for later lines of therapy in patients with mCRC with 2 on-demand video segments and the accompanying downloadable slides, each with expert discussion of the latest clinical data.

Tanios Bekaii-Saab
Tanios Bekaii-Saab, MD, FACP
Axel Grothey Headshot
Axel Grothey, MD

Video Module

Downloadable Slideset

In this downloadable slideset, expert faculty discuss optimal dosing and patient communication strategies in later lines of therapy for mCRC to maximize benefit and mitigate adverse events.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Axel Grothey Headshot Axel Grothey, MD Released: August 29, 2018
This activity is supported by an educational grant from
Bayer Healthcare Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?